Malignant Solid Tumor Clinical Trials

53 clinical trials for Malignant Solid Tumor across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Personalized Neoantigen-pulsed Autologous Dendritic Cell Injections for Malignant Solid Tumors — RECRUITING · NA
• Clinical Evaluation of [68Ga]Ga-ELI411 PET Imaging in Adult Patients With Solid Tumors — RECRUITING · PHASE1
• A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors. — RECRUITING · PHASE2
• ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu — RECRUITING · PHASE1
• Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors — RECRUITING · PHASE1
• Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients — RECRUITING · PHASE1
• Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors — RECRUITING · PHASE1
• Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors — RECRUITING · PHASE1
• CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS) — RECRUITING
• A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies — RECRUITING · PHASE1
• Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors — RECRUITING · PHASE1
• Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy — TERMINATED · PHASE1
• GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid Tumors — WITHDRAWN · PHASE2
• A Clinical Study Comparing the Bioavailability of HRS-2189 Tablets — NOT_YET_RECRUITING · PHASE1
• Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT — TERMINATED · PHASE1
• Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors — COMPLETED · PHASE1
• A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors — TERMINATED · PHASE1
• A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors — TERMINATED · PHASE1
• A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients — TERMINATED · PHASE1
• A Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients Malignancies — COMPLETED · PHASE1
• Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects — COMPLETED · PHASE1
• A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence — OTHER · PHASE2
• Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) — ACTIVE_NOT_RECRUITING · PHASE2
• A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid Tumors — OTHER · PHASE1
• An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab — COMPLETED · PHASE1
• Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors — OTHER · PHASE1
• Safety and Bioimaging Trial of DS-8895a in Patients With Advanced EphA2 Positive Cancers — COMPLETED · PHASE1
• RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD) — TERMINATED · PHASE1
• Clinical Research on Comprehensive Treatment of Tuberculosis With Malignant Solid Tumor — COMPLETED · PHASE1
• A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors — COMPLETED · PHASE2
• Pragmatic Research of Acupuncture and Counseling eXtended to Inpatient Services — COMPLETED · NA
• An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies — COMPLETED · PHASE2
• A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer — COMPLETED · PHASE1
• A Safety and Pharmacokinetic Phase I/Ib Study of AMC303 in Patients With Solid Tumours — COMPLETED · PHASE1
• ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan — COMPLETED · PHASE1
• A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours. — COMPLETED · PHASE1
• A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab — COMPLETED · PHASE1
• A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin — COMPLETED · PHASE2
• Targeted T-cell Therapy in Solid Tumors — OTHER · PHASE1
• A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread — COMPLETED · PHASE1
• Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation — COMPLETED
• Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors — TERMINATED · PHASE1
• Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors — COMPLETED · PHASE1
• EXtendedAnalysis for Cancer Treatment — OTHER · NA
• A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001 — TERMINATED · PHASE1

Refine this search